GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (WBO:EWLS) » Definitions » EV-to-Revenue

Edwards Lifesciences (WBO:EWLS) EV-to-Revenue

: 8.60 (As of Today)
View and export this data going back to 2019. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Edwards Lifesciences's enterprise value is €47,884 Mil. Edwards Lifesciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €5,570 Mil. Therefore, Edwards Lifesciences's EV-to-Revenue for today is 8.60.

The historical rank and industry rank for Edwards Lifesciences's EV-to-Revenue or its related term are showing as below:

WBO:EWLS' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.32   Med: 8.49   Max: 15.72
Current: 8.47

During the past 13 years, the highest EV-to-Revenue of Edwards Lifesciences was 15.72. The lowest was 3.32. And the median was 8.49.

WBO:EWLS's EV-to-Revenue is ranked worse than
79.61% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: 3 vs WBO:EWLS: 8.47

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-18), Edwards Lifesciences's stock price is €81.31. Edwards Lifesciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €9.14. Therefore, Edwards Lifesciences's PS Ratio for today is 8.90.


Edwards Lifesciences EV-to-Revenue Historical Data

The historical data trend for Edwards Lifesciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.03 12.82 15.30 8.33 7.49

Edwards Lifesciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.33 9.03 10.00 7.03 7.49

Competitive Comparison

For the Medical Devices subindustry, Edwards Lifesciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences EV-to-Revenue Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's EV-to-Revenue falls into.



Edwards Lifesciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Edwards Lifesciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=47884.474/5570.014
=8.60

Edwards Lifesciences's current Enterprise Value is €47,884 Mil.
Edwards Lifesciences's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €5,570 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Edwards Lifesciences  (WBO:EWLS) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Edwards Lifesciences's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=81.31/9.141
=8.90

Edwards Lifesciences's share price for today is €81.31.
Edwards Lifesciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €9.14.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Edwards Lifesciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences (WBO:EWLS) Business Description

Traded in Other Exchanges
Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (WBO:EWLS) Headlines

No Headlines